en-us
  • zh-tw
  • en-us
  • Home
  • About Pharmasaga
    • Vision Development & Milestones
    • Organization
    • Awards
  • R&D
    • New Drug
    • Core Technology
    • Diabetes
    • Oncology
  • Investors
    • Financial Statements
    • Sharholder
    • Corporate Governance
    • Investor Conference
  • News Center
    • News
    • Investor Related
    • Company Related
  • Others
    • Join Pharmasaga
    • Contact Us
More
Menu

News Center


News
Investor Related
Company Related

News

  • [NEWS] PharmaSaga to Compete for the Startup Pitch Competition Championship at BIO North America.
  • [2025] PharmaSaga's PS1 Diabetes Drug Shows Cure Potential, Launches Taiwan/U.S. Clinical Trials.
  • [2025] Taiwan at BIO 2025 North America: All-Age Healthcare and Global Connectivity.
  • [2025] PharmaSaga Biotech Reaches Global Finals (Again) at 2025 BIO US Convention
  • [Taiwan's Biotech Success at BIO 2022] PharmaSaga and Sutech Reach Global Startup

Contact Us

  • Pharmasaga
  • Phone number : + 886-2-27938665
  • E-mail : contact@pharmasaga.com
  • Address : 22 F.-1, No. 93, Sec. 1, Xintai 5th Rd., Xizhi Dist., New Taipei City 221416, Taiwan (R.O.C.)

Links 

  • Taiwan Clinical trial
  • PDIA4 publication in EMBO
  • PDIA4 publication in CMLS
  • Clinical trial information of PS1

Contact Us

Images provided by Pexels
Cookies
Languages
  • 中文 (繁體)
  • American English
我們使用了 cookies 來確保我們網站的運作正常與安全性,並為您提供最佳的使用體驗。

Advanced settings

您可以在此自訂您的 cookie 偏好。啟用或關閉以下這些類別,並儲存您的選擇。

必要 cookies 對於網站與註冊過程的安全性和正確運作都至關重要。
功能性 cookies 會儲存並啟用您在網站上的 cookie 偏好。
效能性 cookies 能夠幫助觀察網站的表現狀況。
行銷性 cookies 能夠讓我們衡量與分析網站的成效。